About NEXTONE Pharmaceuticals
NEXTONE Pharmaceuticals is a Healthcare company based in Lucknow (India) founded in 2020. Pharmaceutical manufacturing and distribution in healthcare segments. The company has 1 employees. Its Indian entity Nextone Pharmaceuticals Private Limited reported revenue of ₹13.5 Lakh. NEXTONE Pharmaceuticals offers products and services including Udione and Dceplin. Its focus areas include Pharmaceuticals, Drug Manufacturing, Supplements and Specialty Medicines and Distribution.
Company details
NEXTONE Pharmaceuticals is recognized as a rapidly growing entity that deals with medical segments such as supplement medicine, dermatology, cardiology, and endocrinology. Knowledge is valued to develop innovative solutions and manage change effectively. Global recognition has been achieved within a short period, with major expansion plans being pursued. Quality is ensured through careful measurements, and customer commitments are delivered based on requirements. The company is trusted by over 1,500 chemists and dealers, along with distributors and patients, emphasizing a focus on health solutions.
- Headquarters Lucknow, India
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social Facebook Instagram
- Legal Name Nextone Pharmaceuticals Private Limited
- Date of Incorporation 23 Sep, 2020
- Jurisdiction Lucknow, Uttar Pradesh, India
- Annual Revenue₹13.5 Lakh
FY 2024 · +65% YoY
- Net Profit₹45,584
FY 2024 · 3% margin
- EBITDA₹80,859
FY 2024 · 6% margin
- Employee Count1
Associated legal entities of NEXTONE Pharmaceuticals
NEXTONE Pharmaceuticals operates through Nextone Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nextone Pharmaceuticals Private Limited CIN U51909UP2020PTC135071 | Active | 23 Sep 2020 | Lucknow, Uttar Pradesh | ₹0.1 Cr | 2 | View details |
Products & Services of NEXTONE Pharmaceuticals
NEXTONE Pharmaceuticals offers a comprehensive portfolio of products and services, including Udione and Dceplin.
Improved hepatic health is provided for overall good health through this product.
The complete nutritional solution is offered to meet various health requirements.
Board of directors of Nextone Pharmaceuticals Private Limited (NEXTONE Pharmaceuticals)
Nextone Pharmaceuticals Private Limited is the primary company behind NEXTONE Pharmaceuticals. The board of Nextone Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Dhirender Kumar Tripathi, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dhirender Kumar Tripathi DIN 08890414 | Director | 23 Sep 2020 | 6 yrs 1 mo | Nextone Pharmaceuticals Private Limited |
| Durgesh Kumar Tripathi DIN 08890413 | Director | 23 Sep 2020 | 6 yrs 1 mo | Nextone Pharmaceuticals Private Limited |
Financials of NEXTONE Pharmaceuticals
Figures of Nextone Pharmaceuticals Private Limited, the primary company behind NEXTONE Pharmaceuticals, for FY 2024. Revenue was ₹13.5 Lakh (+65% year on year). Net profit was ₹45,584 (3% margin). EBITDA was ₹80,859 (6% margin). Revenue has grown at a compounded annual rate of +107% over three years.
- ₹13.5 LakhRevenue · FY 2024 · +65% YoY
- ₹45,584Net profit · 3% margin
- ₹80,859EBITDA · 6% margin
- ₹8 LakhPaid-up capital
- +107%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Nextone Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for NEXTONE Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NEXTONE Pharmaceuticals
NEXTONE Pharmaceuticals was founded in 2020.
NEXTONE Pharmaceuticals is headquartered in Lucknow, India. It is registered at Lucknow, Uttar Pradesh, India.
NEXTONE Pharmaceuticals has 1 employees.
The primary company behind NEXTONE Pharmaceuticals, Nextone Pharmaceuticals Private Limited, reported revenue of ₹13.5 Lakh for FY 2024, up 65% year on year.
NEXTONE Pharmaceuticals is recognized as a rapidly growing entity that deals with medical segments such as supplement medicine, dermatology, cardiology, and endocrinology. Knowledge is valued to develop innovative solutions and manage change effectively. Global recognition has been achieved within a short period, with major expansion plans being pursued. Quality is ensured through careful measurements, and customer commitments are delivered based on requirements. The company is trusted by over 1,500 chemists and dealers, along with distributors and patients, emphasizing a focus on health solutions.
NEXTONE Pharmaceuticals offers Udione and Dceplin.
NEXTONE Pharmaceuticals operates through Nextone Pharmaceuticals Private Limited.
The legal entities of NEXTONE Pharmaceuticals currently have 2 directors, including Dhirender Kumar Tripathi, Durgesh Kumar Tripathi.